Literature DB >> 17385302

The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet's disease.

Mehmet Sahin1, Mustafa Yildiz, Sevket Ercan Tunc, Sureyya Cerci, Harun Suslu, Erkan Cure, Ali Kutlucan.   

Abstract

Articular involvement was reported to be present in approximately 5-76% of Behçet patients. Therefore, we need a useful non-invasive method to detect articular involvement early in Behçet patients with nonspecific complaints. We aimed to evaluate the usefulness of 99mTc-methylene diphosphonate (Tc-99m-MDP) bone scintigraphy in the detection of the articular involvement of Behçet's disease (BD). Bone scintigraphy with Tc-99m-MDP was performed in 32 (17 male, 15 female) consecutive patients with BD. The sacroiliac (SI) joints with SI index higher than 1.34 were diagnosed as having sacroiliitis. Although joint complaints were present in only 8 (25%) patients, we detected joint involvement by scintigraphy in 27/32 (84.4%) Behçet patients mostly affecting the knees (62.5%), ankles (59.4%), SI joints (25%), wrists (21.9%), shoulders (18.7%), elbows (12.5%) and hips (3.1%). The articular involvement was monoarticular in four cases (12.5%) and was oligoarticular in the remaining. There was no correlation between joint involvement and age, gender, disease duration, drug usage or other clinical manifestations. Despite the fact that our patients were clinically asymptomatic and had normal pelvis radiography, sacroiliitis was found in 8 patients (25%). Bone scintigraphy is sensitive in the diagnosis of joint involvement allowing earlier diagnosis and showing the presence of articular involvement, especially in SI joints.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17385302     DOI: 10.1007/bf02984675

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  1 in total

1.  Ultrasonographic Measurement of the Femoral Cartilage Thickness in Patients with Behçet's Disease.

Authors:  I Batmaz; M Kara; T Tiftik; M Yildiz; R Çevik; L Özçakar
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.